NPPES file of Aug 9, 2026

Sami Abuqayyas, M.D.

Pulmonary Disease Physician · Danville, IN

Sami Abuqayyas, M.D. is a pulmonary disease physician with a practice address in Danville, Indiana, and NPI 1780024273, issued on Jun 27, 2013. Check the license (Indiana 01087264A, as entered in NPPES) on the Medical Licensing Board of Indiana; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1780024273
Name
Sami Abuqayyas
Credential
M.D.
Primary taxonomy
Pulmonary Disease Physician 207RP1001X
License number
01087264A IN
Self-reported in NPPES; status is on the state search
Practice location
112 Hospital LN Ste 303, Danville, IN 46122
Phone
(317) 718-4000
Enumerated
Jun 27, 2013
Record last updated
Mar 10, 2022
Fax
(317) 718-4005
Medicare enrollment
Enrolled (PECOS I20220315000581); accepts Medicare assignment
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 112 Hospital LN Ste 303

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Sumit Chawla, M.D.Pulmonary Disease Physician1407122740
  2. Edwin Jackson, DOCritical Care Medicine (Internal Medicine) Physician1972827335
  3. Lirim Krveshi, DOPulmonary Disease Physician1255759536
  4. Beau Semler, NPGerontology Nurse Practitioner1972194561

Verify Sami Abuqayyas in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMedical Licensing Board of Indiana
    Search for license 01087264A
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Indiana license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

75% fewer Medicare Part D claims than the average pulmonary disease physician in 2024

361 Medicare Part D claims for 89 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 76% of claims.

  1. Sami Abuqayyas361
  2. Specialty average1,425

Most prescribed

  1. Budesonide-Formoterol Fumarate33 claims
  2. Stiolto Respimat31 claims
  3. Albuterol Sulfate Hfa28 claims
  4. Breo Ellipta27 claims
  5. Trelegy Ellipta25 claims
  6. Incruse Ellipta24 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $489.57

21 payments; by number, the most common kind was food and beverage; the largest payer was GlaxoSmithKline, LLC. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Sami Abuqayyas$489.57
  2. Specialty average$5,159.88

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Hendricks County HospitalDanville, IN

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Pulmonary Disease Physician providers in Indiana

There are 280 pulmonary disease physician records in Indiana.

Other pulmonary disease physician records in Indiana

  1. Faheem Abbasi, MDIndianapolis, IN1043486343
  2. Ibrahim Abou Daya, MDFort Wayne, IN1790950715
  3. Salim Abou Jaoude, MDLafayette, IN1043280670
  4. Mohamed Abou-Rayan, MDBloomington, IN1639356447
  5. Yaser Abu El-Sameed, M.D.Bloomington, IN1104950542
  6. Mirza Abu Sayeem, MBBSMarion, IN1497435960
  7. Sarfraz Ahmad, MDGreenwood, IN1689850422
  8. Nawar Al Nasrallah, MDFishers, IN1558674408
  9. Mohannad Al-Khateeb, MDEvansville, IN1720690555
  10. Mazen Alakhras, MDLafayette, IN1285617803

Common questions

What is Sami Abuqayyas, M.D.'s NPI number?

Sami Abuqayyas, M.D.'s National Provider Identifier (NPI) is 1780024273, issued on Jun 27, 2013. An NPI identifies a provider in billing; it is not a license.

Where is Sami Abuqayyas, M.D. located?

The NPPES record lists a practice address at 112 Hospital LN Ste 303, Danville, IN, 46122. Phone: (317) 718-4000. Providers update this record themselves, so call before visiting.

How can I verify Sami Abuqayyas, M.D.'s license?

NPPES lists Indiana license number 01087264A, as entered by the provider. Search the Medical Licensing Board of Indiana at https://www.in.gov/pla/professions/physicians-home/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Sami Abuqayyas, M.D. prescribe under Medicare Part D?

In 2024, Sami Abuqayyas, M.D. had 361 Medicare Part D claims for 89 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.